Stockhead’s Tylah Tully unpacks the latest from Lumos Diagnostics (ASX:LDX), who have enrolled its 500th patient in a CLIA waiver study for FebriDx, its rapid point-of-care diagnostic test to ...

Lumos isn't bogged down by slow-moving gantry heads. Instead, it's built around a Galvo system —the same kind used in high-speed industrial lasers, where mirrors redirect the beam at blinding ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces that the recently ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries proudly announces the third party ...

OxyContin maker Purdue Pharma ’s latest plan to settle thousands of lawsuits over the toll of opioids could soon move forward after every U.S. state involved agreed to it.

Lumos’s FebriDx included in Australian trial aimed at reducing unnecessary antibiotic prescribing for respiratory infections in primary care FebriDx tests one of a suite of interventions being ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company and the Singapore Eye Research Institute (SERI), a leading ophthalmology research institution, today announced ...

LabVantage Pharma is the only pre-configured and pre-validated pharmaceutical LIMS in the world. This greatly lowers the deployment cost (85%) and time (75%) compared to a traditional LIMS ...

Aurobindo Pharma Ltd. Annual stock financials by MarketWatch. View the latest AUROPHARMA financial statements, income statements and financial ratios.

Dual Primary Concentration Requirements: Pharmaceutical Management students that wish to have a dual Primary Concentration with Marketing, must take 22:630:604 Marketing Research as one of their ...

The state of Maine is expected to receive $26 million from Purdue Pharma and its owners, the Sackler family, as part of the $7.4 billion settlement that will resolve lawsuits over the company's ...

View the latest Apellis Pharmaceuticals Inc. (APLS) stock price, news, historical charts, analyst ratings and financial information from WSJ.